Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12
Michael Crump, John Kuruvilla, Stephen Couban, David A. MacDonald, Vishal Kukreti, C. Tom Kouroukis, Morel Rubinger, Rena Buckstein, Kevin R. Imrie, Massimo Federico, Nicola Di Renzo, Kang Howson-Jan, Tara Baetz, Leonard Kaizer, Michael Voralia, Harold J. Olney, A. Robert Turner, Jonathan Sussman, Annette E. Hay, Marina S. DjurfeldtRalph M. Meyer, Bingshu E. Chen, Lois E. Shepherd
Dive into the research topics of 'Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12'. Together they form a unique fingerprint.